About
Needle-free Injection
Areas of Focus
Categories
Drug Delivery DeviceDrug Delivery & Formulation
Team (13)
Daniel TEPER
Member
CROSSJECT
team_member
Didier MORIN
Industrial Director
CROSSJECT
team_member
Dr Jean-Francois LOUMEAU
Member
CROSSJECT
team_member
Dr Yannick PLÉTAN
Member
CROSSJECT
team_member
Eric NEMETH
Member
CROSSJECT
team_member
Isabelle LIEBSCHUTZ
Director of Quality and Regulatory Affairs
CROSSJECT
team_member
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
434
By Phase
NA: 4PHASE1: 2
By Status
COMPLETED: 4RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06279689Lead Sponsor
Echography Study_Anthropometric Measurements
NARecruiting
90 participants
Started: Feb 13, 2024 · Completed: Sep 30, 2024
NCT05967013Lead Sponsor
Evaluation by Magnetic Resonance Imaging of Intramuscular Injections Performance in Thigh With 2 Configurations of the Needle-free Injector ZENEO®.
NACompleted
63 participants
Started: Jun 12, 2023 · Completed: Feb 16, 2024
NCT05026567Lead Sponsor
Bioavailability Study of Midazolam Administered as a Solution by Conventional Syringe or ZENEO®
PHASE1Completed
40 participants
Started: May 9, 2022 · Completed: Jul 15, 2022
NCT03225638Lead Sponsor
Performance Evaluation by Magnetic Resonance Imaging (MRI) of Intramuscular Thigh Injections With 3 Configurations of Needle-free Injector (ZENEO®)
NAUnknown
86 participants
Started: Sep 1, 2017 · Completed: Dec 29, 2017
NCT03044301Lead Sponsor
Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)
NACompleted
97 participants
Started: Mar 31, 2015 · Completed: Jun 30, 2016
Locations (1)
Headquarters
Dijon, France
Map
Loading map...